These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre. Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856 [TBL] [Abstract][Full Text] [Related]
3. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E; J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy. van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169 [TBL] [Abstract][Full Text] [Related]
5. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
6. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction. Kutyifa V; Vermilye K; Solomon SD; McNitt S; Moss AJ; Daimee UA Eur J Heart Fail; 2019 Mar; 21(3):360-369. PubMed ID: 30592353 [TBL] [Abstract][Full Text] [Related]
8. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology. Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of patients with and without super-response to CRT-D. Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005 [TBL] [Abstract][Full Text] [Related]
10. Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study. Hürlimann D; Schmidt S; Seifert B; Saguner AM; Hindricks G; Lüscher TF; Ruschitzka F; Steffel J Clin Res Cardiol; 2015 Feb; 104(2):136-44. PubMed ID: 25301085 [TBL] [Abstract][Full Text] [Related]
11. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR; Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828 [TBL] [Abstract][Full Text] [Related]
12. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C; Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006 [TBL] [Abstract][Full Text] [Related]
13. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial). Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116 [TBL] [Abstract][Full Text] [Related]
14. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H; Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084 [TBL] [Abstract][Full Text] [Related]
15. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study. Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860 [TBL] [Abstract][Full Text] [Related]
16. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962 [TBL] [Abstract][Full Text] [Related]
17. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial. Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A; Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607 [TBL] [Abstract][Full Text] [Related]
18. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy. Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980 [TBL] [Abstract][Full Text] [Related]
19. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience. Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869 [TBL] [Abstract][Full Text] [Related]
20. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ; Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]